Lee's Pharmaceutical Holdings Limited (HKG:0950)
1.210
+0.075 (6.61%)
Sep 18, 2026, 3:57 PM HKT
HKG:0950 Revenue
Lee's Pharmaceutical Holdings had revenue of 796.57M HKD in the half year ending June 30, 2026, with 21.00% growth. This brings the company's revenue in the last twelve months to 1.54B, up 7.05% year-over-year. In the year 2025, Lee's Pharmaceutical Holdings had annual revenue of 1.44B with 2.57% growth.
Revenue (ttm)
1.54B
Revenue Growth
+7.05%
P/S Ratio
0.46
Revenue / Employee
1.41M
Employees
1,094
Market Cap
712.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.44B | 36.01M | 2.57% |
| Dec 31, 2024 | 1.40B | 346.94M | 32.95% |
| Dec 31, 2023 | 1.05B | -180.11M | -14.61% |
| Dec 31, 2022 | 1.23B | -33.01M | -2.61% |
| Dec 31, 2021 | 1.27B | 49.44M | 4.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.90B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.57B |
| Dawnrays Pharmaceutical (Holdings) | 1.32B |
| Golden Throat Holdings Group Company | 1.04B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.04B |
| JBM (Healthcare) | 834.63M |
| Wai Yuen Tong Medicine Holdings | 683.44M |